Number of Clinical Trials 2019
Explore the number of clinical trials conducted in various countries; critical for medical research and innovation.
Newer data is available: Number of Clinical Trials by country 2024 β
Where does your country rank? Pick it to see its position.
Related Health statistics
More βInteractive Map
Complete Data Rankings
Analysis: These countries represent the highest values in this dataset, showcasing significant scale and impact on global statistics.
- #149
Somalia
- #148
Saint Kitts and Nevis
- #147
State of Palestine
- #146
Mongolia
- #145
Micronesia (Fed. States of)
- #144
Mauritius
- #143
Malta
- #142
Liberia
- #141
Latvia
- #140
Honduras
Context: These countries or territories have the lowest values, often due to geographic size, administrative status, or specific characteristics.
Insights by country
Jordan
In 2019, Jordan ranked #46 globally with a total of 32 clinical trials. This figure is notable, especially when compared to many neighboring countries in the Middle East, which often have fewer trials due to varying regulatory environments. Jordan's strategic location, coupled with its commitment to healthcare advancements and research initiatives, has fostered a conducive environment for clinical research.
Kenya
In 2019, Kenya ranked #47 globally with a total of 32 clinical trials. This figure is relatively low compared to regional leaders, reflecting a growing but still limited research infrastructure in East Africa. Factors such as a young population, increasing investment in healthcare, and partnerships with international organizations have been pivotal in fostering clinical research in the country.
Argentina
In 2019, Argentina ranked #41 globally with a total of 35 clinical trials. This figure is relatively low compared to regional leaders like Brazil, which has a significantly higher number of trials. Factors such as Argentina's established pharmaceutical industry, regulatory environment, and a strong presence of medical research institutions contribute to its clinical trial landscape.
Azerbaijan
Azerbaijan ranked #130 globally with a total of 1 clinical trial in 2019. This figure is notably low compared to regional neighbors, which typically have higher participation in clinical research. Factors contributing to this limited number include a relatively small population and less developed healthcare infrastructure, which may hinder the capacity for conducting extensive clinical studies.
Bahrain
Bahrain ranked #112 globally with a total of 2 clinical trials in 2019. This figure is notably low compared to many neighboring countries, which often have more robust research infrastructures. The limited number of clinical trials in Bahrain can be attributed to its smaller population and a relatively nascent research ecosystem, which faces challenges in attracting international pharmaceutical investments.
Armenia
In 2019, Armenia ranked #66 globally with a total of 13 clinical trials. This number is relatively low compared to leading countries in clinical research, such as the United States, which hosts thousands of trials annually. The limited number of clinical trials in Armenia can be attributed to its smaller population and developing healthcare infrastructure, which presents challenges in attracting international research investments.
Denmark
In 2019, Denmark ranked #13 globally with a total of 314 clinical trials. This figure is significantly higher than the global average, reflecting Denmark's robust healthcare infrastructure and strong emphasis on medical research. The country's favorable regulatory environment and investment in biotechnology contribute to its high number of clinical trials, making it an attractive location for pharmaceutical and medical device companies.
India
In 2019, India ranked #20 globally with a total of 157 clinical trials. This figure is notable given that India is a key player in the global clinical research landscape, often attracting trials due to its diverse patient population and relatively lower costs compared to Western countries. The country's robust pharmaceutical industry and supportive regulatory environment further contribute to its prominence in clinical research.
Iraq
In 2019, Iraq ranked #58 globally with a total of 18 clinical trials. This figure is notably lower than the global average, reflecting challenges in research infrastructure compared to leading countries in clinical research. Factors contributing to this statistic include ongoing political instability and limited investment in healthcare research, which hinder the development of clinical trial capabilities in the country.
Switzerland
In 2019, Switzerland ranked #15 globally with a total of 295 clinical trials. This figure is notably higher than the global average, reflecting Switzerland's strong reputation in pharmaceutical research and development. The country's robust healthcare system, coupled with a high concentration of leading biotech firms and research institutions, drives its clinical trial activity.
Analysis & Context
In 2019, the United States led the world in the Number of Clinical Trials with 6,795 studies, while the global range spanned from a minimum of 1 to this maximum. The global average number of clinical trials conducted across 149 countries was approximately 126.92, with the median value at 8, highlighting a significant disparity in research activity worldwide.
Global Leaders in Clinical Trials
Clinical trials are pivotal for advancing medical research and innovation, and the distribution of these trials in 2019 underscores global disparities. The United States dominated the field with 6,795 trials, far surpassing other nations. This leadership is likely driven by the country's substantial investment in healthcare infrastructure, a strong pharmaceutical industry, and a regulatory environment that supports research and development. Following the U.S., France and China conducted 1,234 and 908 trials, respectively. France's robust public health system and China's growing investment in biotechnology contribute to their high numbers. Additionally, Turkey and the United Kingdom reported 907 and 773 trials, reflecting their strategic focus on expanding research capabilities.
Factors Behind Low Clinical Trial Numbers
At the other end of the spectrum, countries like Albania, Antigua and Barbuda, and Azerbaijan each reported only 1 clinical trial. Several factors contribute to these low figures, including limited financial resources, insufficient healthcare infrastructure, and smaller population sizes that offer less potential for participant recruitment. These limitations can hinder a country's ability to conduct and support clinical research, often resulting in a reliance on international collaborations or external funding to initiate trials.
Significant Year-over-Year Changes
Examining changes from previous years provides insight into shifting patterns in clinical research. The United States saw an increase of 510 trials, an 8.1% rise, underscoring its ongoing commitment to research expansion. Turkey experienced one of the most significant increases, adding 373 trials, a 69.9% surge, possibly due to enhanced governmental support and international collaborations. Similarly, China and Egypt increased their trial numbers by 223 (32.6%) and 211 (51.3%), respectively, reflecting their strategic initiatives to bolster their research sectors.
Conversely, some countries experienced declines. Japan reported a reduction of 43 trials, a 17.8% decrease, which could relate to regulatory challenges or shifts in research priorities. Similarly, Israel and Norway saw decreases of 42 (27.8%) and 22 (16.1%) trials, respectively, suggesting possible reallocations of resources or strategic pivots in research focus.
Implications for Global Health Research
The disparities in the Number of Clinical Trials across countries have profound implications for global health research. Nations with high trial numbers often lead in medical innovation, contributing to advancements in treatments and therapies that can be disseminated worldwide. Conversely, countries with fewer trials may miss opportunities for early access to new treatments and participation in groundbreaking research. Addressing these disparities requires international cooperation, increased funding, and policy reforms to create an enabling environment for clinical research in underrepresented regions.
In conclusion, the 2019 data on clinical trials highlights both the achievements and challenges in global medical research. Understanding the underlying factors driving these patterns is essential for fostering a more equitable distribution of research opportunities worldwide.
Frequently Asked Questions About Number of Clinical Trials in 2019
Which country had the highest number of clinical trials in 2019?
The United States had the highest number of clinical trials in 2019, with 6,795 trials.
What was the average number of clinical trials conducted per country in 2019?
The average number of clinical trials conducted per country in 2019 was 127.
Which country had the lowest number of clinical trials in 2019?
Albania had the lowest number of clinical trials in 2019, with just 1 trial.
What was the median number of clinical trials conducted by countries in 2019?
The median number of clinical trials conducted by countries in 2019 was 8.
How many countries conducted only 1 clinical trial in 2019?
Ten countries conducted only 1 clinical trial in 2019, including Albania, Antigua and Barbuda, and Azerbaijan.
Which countries were in the top 3 for the number of clinical trials in 2019?
The top 3 countries for the number of clinical trials in 2019 were the United States with 6,795 trials, France with 1,234 trials, and China with 908 trials.
Data Source
Number of clinical trials | ClinicalTrials.gov via Our World in Data
Data produced by ClinicalTrials.gov, compiled and published by Our World in Data as "Number of clinical trials".
Visit Data SourceCite this page
Geo Factbook. (n.d.). Number of Clinical Trials by Country, 2019. Retrieved November 16, 2026, from https://geofactbook.com/fact/number-of-clinical-trials/2019
The figures on this page come from Number of clinical trials | ClinicalTrials.gov via Our World in Data. For academic work, cite the original source as well.
βΊEmbed this ranking on your site
Free to embed with attribution. Shows the top 10 countries and links back to the full ranking.